Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities
The U.K. is rejoining the European Union’s (EU’s) $100 billion research program Horizon Europe, after being locked out of the deal amid post Brexit tensions for more than two years.
This comes after months of...
Are these 10 biotech recruiters on your radar this year?
The process of hunting for recruits can be a struggle for many companies, particularly when they have an ideal candidate in mind. And many at times, for the life science/biotech industry, due to the...
The biggest private biotech investments in January 2023
The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January 2023. Around the world, synthetic biology players and firms developing treatments for hormonal disorders attracted the biggest funding rounds.
2023...
JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases
The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has issued a call for multinational research on large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases.
Neurodegenerative diseases are debilitating and...
To avoid stagnation, the EU must refine its ATMP regulation
Over the decades, the EU has spearheaded the adoption of advanced therapy medicinal products (ATMPs) such as cell and gene therapies. However, changes are needed to ATMP regulations to keep Europe competitive with the...
Mycotechnology and IFF join forces in Europe to create better food system
Mycotechnology, a company using mycelia, the roots of mushrooms, and IFF have formed a partnership to co-develop alternative proteins.
The two companies have already partnered in the U.S. and the new collaboration in Europe, they...
ResQ Biotech is using bacteria to discover Alzheimer’s treatments
Protein misfolding underlies many incurable conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). The Greek startup ResQ Biotech is harnessing bacteria to test potential peptide treatments for these diseases.
There are many diseases...
